Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.

Johnson & Johnson JNJ announced that the phase IIb JASMINE study, which evaluated its pipeline candidate, nipocalimab, for ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

For people living with lupus, pain can be one of the most persistent and difficult symptoms to manage. But the good news is that a combination of medical treatments, lifestyle changes and ...

Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the formation of a new philanthropic venture fund Lupus Ventures. The Fund is dedicated to advancing ...

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; ...

May is Lupus Awareness Month and Toni Braxton is using the opportunity to speak out about living with this chronic autoimmune disease. In an interview with CBS News Wednesday, the Grammy-winning ...

Which of the statements about the 2025 American College of Rheumatology guideline for the treatment of systemic lupus ...

The star has struggled with joint pain and exhaustion. Lupus is one, but not the only, possible explanation.